Schering Deutschland GmbH

euro adhoc: Schering AG
Schering AG receives FDA approval for new low dose oral contraceptive YAZ(R) with 24-day regimen

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc.   The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@


Schering AG, Germany announced today that the U.S. Food and Drug Administration (FDA) has approved the new low dose, monophasic oral contraceptive YAZ(R) (3mg drospirenone/20 mcg ethinyl estradiol). It is the first pill with the innovative progestin drospirenone, and a low dose of ethinyl estradiol in a new dosing regimen of 24 days of active hormone pills and four days of placebo.

YAZ(R) will be launched in the U.S. in April 2006 by Berlex, Inc., a U.S. affiliate of Schering.

Schering continues to pursue FDA approval of YAZ(R) for the treatment of emotional and physical symptoms of premenstrual dysphoric disorder (PMDD), which is a severe form of  premenstrual symptoms (PMS), among women who desire contraception.

@@start.t2@@end of announcement                                                 euro adhoc 17.03.2006 06:25:37

ots Originaltext: Schering Deutschland GmbH
Im Internet recherchierbar:

Further inquiry note:
Oliver Renner
Head Corporate Business Communication
Tel.:  +49 (0)30 468 12431
Fax: +49 (0)30 468 16646

Branche: Pharmaceuticals
ISIN:      DE0007172009
WKN:        717200
Index:    DAX, CDAX, HDAX, Prime All Share
Börsen:  Baden-Württembergische Wertpapierbörse / regulated dealing
              Niedersächsische Börse zu Hannover / regulated dealing
              New York / ADR
              Frankfurter Wertpapierbörse / official dealing/prime standard
              Börse Berlin-Bremen / official dealing
              Hamburger Wertpapierbörse / official dealing
              Börse Düsseldorf / official dealing
              Bayerische Börse / official dealing

Weitere Meldungen: Schering Deutschland GmbH

Das könnte Sie auch interessieren: